Last reviewed · How we verify

clomiphene citrate treatment

Sheba Medical Center · Phase 3 active Small molecule

clomiphene citrate treatment is a Selective estrogen receptor modulator (SERM) Small molecule drug developed by Sheba Medical Center. It is currently in Phase 3 development for Anovulation and infertility in women, Male infertility / hypogonadism.

Clomiphene citrate is a selective estrogen receptor modulator (SERM) that blocks negative feedback of estrogen on the hypothalamic-pituitary-gonadal axis, thereby increasing gonadotropin secretion to stimulate ovulation or spermatogenesis.

Clomiphene citrate is a selective estrogen receptor modulator (SERM) that blocks negative feedback of estrogen on the hypothalamic-pituitary-gonadal axis, thereby increasing gonadotropin secretion to stimulate ovulation or spermatogenesis. Used for Anovulation and infertility in women, Male infertility / hypogonadism.

At a glance

Generic nameclomiphene citrate treatment
SponsorSheba Medical Center
Drug classSelective estrogen receptor modulator (SERM)
TargetEstrogen receptor (ER-α and ER-β)
ModalitySmall molecule
Therapeutic areaReproductive Endocrinology / Fertility
PhasePhase 3

Mechanism of action

Clomiphene acts as a competitive antagonist at estrogen receptors in the hypothalamus and pituitary gland, preventing the normal inhibitory feedback that estrogen exerts on GnRH and gonadotropin release. This disinhibition leads to increased FSH and LH secretion, which stimulates follicle development in women and testosterone production in men. The net effect is restoration or enhancement of reproductive hormone signaling.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about clomiphene citrate treatment

What is clomiphene citrate treatment?

clomiphene citrate treatment is a Selective estrogen receptor modulator (SERM) drug developed by Sheba Medical Center, indicated for Anovulation and infertility in women, Male infertility / hypogonadism.

How does clomiphene citrate treatment work?

Clomiphene citrate is a selective estrogen receptor modulator (SERM) that blocks negative feedback of estrogen on the hypothalamic-pituitary-gonadal axis, thereby increasing gonadotropin secretion to stimulate ovulation or spermatogenesis.

What is clomiphene citrate treatment used for?

clomiphene citrate treatment is indicated for Anovulation and infertility in women, Male infertility / hypogonadism.

Who makes clomiphene citrate treatment?

clomiphene citrate treatment is developed by Sheba Medical Center (see full Sheba Medical Center pipeline at /company/sheba-medical-center).

What drug class is clomiphene citrate treatment in?

clomiphene citrate treatment belongs to the Selective estrogen receptor modulator (SERM) class. See all Selective estrogen receptor modulator (SERM) drugs at /class/selective-estrogen-receptor-modulator-serm.

What development phase is clomiphene citrate treatment in?

clomiphene citrate treatment is in Phase 3.

What are the side effects of clomiphene citrate treatment?

Common side effects of clomiphene citrate treatment include Hot flashes, Ovarian hyperstimulation syndrome (OHSS), Abdominal discomfort / bloating, Nausea, Visual disturbances, Headache.

What does clomiphene citrate treatment target?

clomiphene citrate treatment targets Estrogen receptor (ER-α and ER-β) and is a Selective estrogen receptor modulator (SERM).

Related